Form 8-K - Current report:
SEC Accession No. 0001390478-17-000002
Filing Date
2017-01-09
Accepted
2017-01-09 07:28:32
Documents
1
Period of Report
2017-01-09
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K gale-201701068xk.htm 8-K 51129
  Complete submission text file 0001390478-17-000002.txt   52483
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 17515794
SIC: 2834 Pharmaceutical Preparations